FDA Approves Screws That Dissolve Inside Your Bones
Published Date: 6/5/2026
Rule
Summary
The FDA is officially classifying absorbable metallic bone fixation fasteners as Class II devices with special safety rules, making them easier to get to patients while keeping them safe and effective. This change helps doctors and patients by reducing red tape and encouraging new, helpful bone-fixing tech. The new rules took effect on June 5, 2026, but have been in place since March 29, 2023, so manufacturers should already be on board.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
New Clinical, Testing, and Labeling Requirements
Manufacturers must meet special controls including clinical data showing full absorption, non-clinical performance testing (complete degradation profile, initial and degrading mechanical performance), biocompatibility, non-pyrogenicity, sterility and shelf-life testing. Labeling must include material composition, absorption byproducts, technical parameters, expiration/shelf life, instructions for revision surgery, time to complete absorption, and a summary of clinical data.
Absorbable Fixators Reclassified to Class II
The FDA has classified absorbable metallic bone fixation fasteners as Class II with special controls. The final order is effective June 5, 2026, and the classification has been applicable since March 29, 2023. FDA says this change reduces regulatory burdens and will enhance patients' access to these devices.
Creates Predicate Pathway for Future Devices
Because FDA used the De Novo process to classify this device, the absorbable metallic bone fixation fastener can serve as a predicate for future similar devices. Other device sponsors can use the less-burdensome 510(k) process instead of submitting a De Novo request or a premarket approval application for substantially equivalent devices.
510(k) Premarket Notification Still Required
FDA states that absorbable metallic bone fixation fasteners are subject to premarket notification under section 510(k). At this time, FDA has not determined that this device type should be exempt under section 510(m), so sponsors must submit a 510(k) before marketing.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11303 — Intent To Exempt Certain Unclassified Medical Devices From Premarket Notification Requirements; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is planning to exempt some unclassified medical devices from the usual premarket notification rules, making it easier and faster for these devices to reach the market. This change affects manufacturers of certain medical devices and could save them time and money. The new guidance is effective starting June 5, 2026, but the FDA is still open to feedback from the public.
2026-11306 — Medical Devices; Orthopedic Devices; Classification of the Shoulder Joint Humeral (Hemi-Shoulder) Ceramic Head/Metallic Stem Cemented or Uncemented Prosthesis
The FDA is officially putting the shoulder joint humeral ceramic head/metallic stem prosthesis into Class II, meaning it now has special safety rules but fewer red tape hurdles. This change helps patients get safer, innovative shoulder implants faster and makes life easier for makers by lowering regulatory costs. The new classification is effective June 5, 2026, but has been in effect since December 16, 2022.
2026-11308 — Medical Devices; Orthopedic Devices; Classification of the Resorbable Calcium Salt Bone Void Filler Containing a Single Approved Aminoglycoside Antibacterial
The FDA is officially putting a special bone filler that slowly dissolves and fights bacteria into a safer, easier-to-manage category called Class II. This change helps make sure the product is safe and effective while speeding up patient access to this cool new tech. It’s been in effect since May 2022, so companies and patients can expect smoother approvals and fewer hoops to jump through.
2026-11060 — Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities-Questions and Answers; Revised Draft Guidance for Industry; Availability
The FDA just released a revised draft guide to help drug and device makers share important cost and coverage info with insurance companies and similar groups. This update clears up how to talk about approved products, unapproved products, and new uses, making it easier for everyone to understand the rules. Companies should send their feedback by August 3, 2026, so the FDA can finalize the guide—potentially speeding up coverage decisions and saving money.
2026-11062 — Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications
The FDA is officially pulling the plug on 16 generic drug approvals because the companies told them these medicines aren’t being sold anymore. This change kicks in on July 6, 2026, and it won’t stop companies from trying again later if they want. If you’re a drug maker or just curious, this means fewer old approvals cluttering the books and a cleaner, fresher drug list.
2026-11101 — Third Annual Animal Drug User Fee Educational Conference; Public Meeting
The FDA is hosting its Third Annual Animal Drug User Fee Educational Conference on July 7, 2026, to help drug makers and animal health experts understand the new animal drug approval process. This free event is both in-person and online, making it easy to join. Stakeholders should register early and can send feedback within 90 days after the meeting to help shape future policies and fees.
Previous / Next Documents
Previous: 2026-11301 — Special Local Regulations; Marine Events Within the USCG East District
The Coast Guard is setting special rules for boats during the Blackbeard Festival on the Hampton River in Virginia from June 13-14, 2026. Boats must follow directions and stay out of certain areas during specific times to keep everyone safe. This means some waterways will be off-limits for short periods, so boaters should plan ahead and expect some delays.
Next: 2026-11304 — Establishment of Class E Airspace; Wickenburg, AZ
Starting September 3, 2026, new Class E airspace will be set up around Wickenburg, Arizona to help pilots fly safely using instruments, especially when the weather isn’t great. This change mainly affects pilots and air traffic controllers by improving flight rules and procedures in the area. No extra costs for the public, just smoother and safer skies!